Entrada Therapeutics, Inc.
TRDA · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Mpm Bioventures 2018, L.P.: Form 4
Insider disclosure · Filed · Report period 04 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- TRDA · 29384C108 - Common Stock
Company details and SEC sources
CIK 0001689375 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TRDA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- One Design Center Place, Suite 17 500, Boston, MA, 02210
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- CycloPorters, Inc. (to 10 Nov 2016)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields